Results 221 to 230 of about 245,125 (261)

Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities

Progress in Retinal and Eye Research, 2021
Scott W Cousins
exaly  

Injectable Anti‐Inflammatory Supramolecular Nanofiber Hydrogel to Promote Anti‐VEGF Therapy in Age‐Related Macular Degeneration Treatment

Advanced Materials, 2023
Zhuang Liu
exaly  

Anti-VEGF-Resistant Retinal Diseases: A Review of the Latest Treatment Options

Cells, 2021
Ron P Gallemore
exaly  

ANTI VEGF - VIEWPOINTS

EyeQuest, 2021
Deepak Agrawal, Muna Bhende, Sourav Sinha, Manish Nagpal, Anand Rajendran   +4 more
openaire   +1 more source

Progress and Challenges of Anti-VEGF Agents and Their Sustained-Release Strategies for Retinal Angiogenesis

Drug Design, Development and Therapy, 2022
Yan Shao, Xiaorong Li
exaly  

Stroke and Anti-VEGF Therapy

Ophthalmology, 2011
Takashi, Ueta, Harushi, Mori, Akira, Kunimatsu, Takuhiro, Yamaguchi, Yasuhiro, Tamaki, Yasuo, Yanagi   +5 more
openaire   +2 more sources

Switching between anti-VEGF agents in the management of refractory diabetic macular edema: A systematic review

Survey of Ophthalmology, 2022
Peter Kertes, Brian Ballios, Parnian Arjmand   +2 more
exaly  

Update on the Management of Diabetic Retinopathy: Anti-VEGF Agents for the Prevention of Complications and Progression of Nonproliferative and Proliferative Retinopathy

Life, 2023
Sophie Bakri, Tyler Bahr
exaly  

Anti-VEGF combined with ocular corticosteroids therapy versus anti-VEGF monotherapy for diabetic macular edema focusing on drugs injection times and confounding factors of pseudophakic eyes: A systematic review and meta-analysis

Pharmacological Research, 2023
Tian Li, Weiming Yan, Chengming Chen
exaly  

Anti-VEGF antibodies

1998
BACA MANUEL, PRESTA LEONARD G, WELLS JAMES A, LOWMAN HENRY B, CHEN YVONNE MAN-YEE   +4 more
openaire   +21 more sources